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An Inspiring Story 
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he was going to die of cancer. Today, 
he is disease-free. Here is his story 
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rel ieving blocked coronary arteries. 
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i s t o r i c a l l y , t h e diag-
nos is of t e r m i n a l ean-
eer has been some-
t h i n g of a d e a t h sen-
tence f o r i t s v i c t i m s . 
B u t w i t h t h e t r e m e n -
dous research a d v a n c e m e n t s 
b e i n g m a d e i n cancer care a n d 
b i o t e c h n o l o g y , i n c r e a s i n g l y m o r e 
"second-ehance-at - l i fe" s tor ies are 
b e i n g t o l d . B i l l S m i t h is one of 
those s tor ies . 
I n O c t o b e r of 1986, S m i t h , of 
H i n g h a m , Mass . , was d iagnosed 
w i t h B-ce l l l y m p h o m a , a s l o w -
d e v e l o p i n g b u t t rea tab le f o r m of 
m a l i g n a n t cancer. T h e n , af ter 
t h r e e years of s e e m i n g l y e f fec t ive 
t r e a t m e n t , he w a s d iagnosed w i t h 
T - c e l l l y m p h o m a , a u n i f o r m l y 
f a t a l cancer t h a t o f t e n progresses 
v e r y r a p i d l y . 
A t f i r s t . S m i t h w a s t r e a t e d 
w i t h c o n v e n t i o n a l c h e m o t h e r a p y , 
b u t t o n o a v a i l . " O n e day, [ m y 
d o c t o r ] c a m e o u t of h i s o f f i ce a n d 
j u s t s h o o k b i s h e a d a n d said, T m 
sorry , w e h a v e n o m e d i c i n e for 
y o u , t h e r e is n o t h i n g I can do . 
C o n v e n t i o n a l c h e m o t h e r a p y i s n ' t 
w o r k i n g , ' " he recal ls . 
D e s p i t e h i s e x t r e m e l y d i s m a l 
prospects . B i l l S m i t h r e m a i n e d op-
t i m i s t i c . "Even w h e n 
c h e m o t h e r a p y d i d n ' t w o r k , m y 
fee l ing . . .was s t i l l v e r y p o s i t i v e . 
D e e p d o w n , I j u s t f e l t t h a t I even-
t u a l l y w o u l d get be t ter . " F i n a l l y , 
w i t h n o o t h e r measures at h i s dis-
posal , h i s d o c t o r re ferred h i m t o 
T h e U n i v e r s i t y H o s p i t a l , w h e r e 
p a t i e n t t r i a l s of an e x p e r i m e n t a l 
n e w d r u g w e r e b e g i n n i n g . B i l l 
S m i t h ' s l i f e was a h o u t t o change. 
S m i t h was e n r o l l e d i n t h e c l i n i -
ca l t r i a l of t h e I L - 2 d i p h t h e r i a 
T'm disease-
free...Tm 
living a 
completely 
normal l ife ' 
— B i l l Smith 
t o x i n , a g e n e t i c a l l y des igned d r u g 
p i o n e e r e d at U H b y John M u r p h y , 
P h . D . , ch ie f of B i o m o l e e u l a r 
M e d i c i n e , a n d deve loped b y 
Seragen, Inc . , a b i o t e c h n o l o g y 
f i r m based i n H o p k i n t o n , Mass . 
U s i n g b i o e n g i n e e r i n g t e c h n i q u e s 
i n t h e l a b o r a t o r y . M u r p h y f o u n d 
t h a t c o m b i n i n g t w o n a t u r a l l y oc-
c u r r i n g p r o t e i n s — i n t e r l e u k i n - 2 
a n d t h e d i p h t h e r i a t o x i n — c r e a t e d 
a t h i r d p r o t e i n , a d r u g , t h a t c o u l d 
a c t u a l l y p e n e t r a t e t h e surface of a 
cancer c e l l a n d k i l l t h e c e l l 
w i t h o u t h a r m i n g h e a l t h y cel ls . 
The road to recovery 
I n M a r c h of 1990, S m i t h e n t e r e d 
t r e a t m e n t . T o m a n y , w h a t was t o 
o c c u r over t h e n e x t t h r e e m o n t h s 
w a s n o t h i n g s h o r t of m i r a c u l o u s . 
" M y face was so b a d l y af fec ted [by 
t h e cancer] t h a t 1 h a d m a r k i n g s 
o n m y nose, forehead a n d cheeks, 
e v e n o n m y b a c k a n d legs," he 
says. "But after t h e f i r s t 10 days 
t o t w o w e e k s o n t h e m e d i c i n e , 
m y face c leared u p b y 65 t o 70 per-
cent . I t was u n b e l i e v a b l e . " 
" [ M r . S m i t h ] came t o see us 
w h e n h i s diseased h a d b e c o m e 
r e a c t i v a t e d , " recal ls P a u l J. Hes-
k e t h , M . D . , S m i t h ' s a t t e n d i n g o n -
co log is t . " T h i s t i m e , t h o u g h , h i s 
l y m p h o m a h a d caused severe s k i n 
les ions , w h i c h is n o t u n u s u a l for 
t h i s t y p e of cancer. H e u n d e r -
w e n t f o u r courses of t h e r a p y a n d 
i t was apparent , even i n t h e f i r s t 
cyc le , t h a t h i s disease was regress-
i n g . By t h e second cycle , h i s s k i n 
les ions h a d s i g n i f i c a n t l y i m -
p r o v e d a n d a l m o s t disappeared." 
By M a y , af ter f o u r courses of 
t r e a t m e n t . B i l l S m i t h was t a k e n 
off t h e t h e r a p y . " A n d i t ' s been 15 
m o n t h s s ince I 've h a d a n y drugs 
w h a t s o e v e r , " says S m i t h . " I ' m 
c o m p l e t e l y disease-free.. . ! fee l bet-
ter n o w t h a n I d i d t h r e e or f o u r 
years ago, w h e n 1 f i r s t came d o w n 
w i t h [B-cel l l y m p h o m a ] . I w a l k 
t w o or t h r e e m i l e s a day; I p l a y 
golf ; I w o r k i n t h e y a r d — I ' m 
l i v i n g a c o m p l e t e l y n o r m a l l i f e . " 
"We have f o l l o w e d M r . S m i t h 
v e r y c lose ly for t h e 15 m o n t h s f o l -
l o w i n g h i s t r e a t m e n t a n d w e have 
n o t been able t o detect a n y s i g n of 
r e c u r r e n t s k i n i n v o l v e m e n t , a n d 
t h e r e w e r e o n l y m i n i m a l — a n d 
n o n t h r e a t e n i n g — t r a c e s of t h e can-
cer i n h i s bone m a r r o w , " says Hes-
k e t h . " T h i s has been a n e x t r a o r d i -
n a r y p e r i o d for h i m because he 
has never gone t h i s l o n g w i t h o u t 
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n e e d i n g some t y p e of t h e r a p e u t i c 
i n t e r v e n t i o n , s u c h as 
c h e m o t h e r a p y or r a d i a t i o n 
t h e r a p y — h e has f u l l y m a i n t a i n e d 
h i s regression." 
H e s t i l l comes t o t h e H o s p i t a l 
f o r b i m o n t h l y exams a n d C A T 
scans every t h r e e m o n t h s , b u t , 
f o r t u n a t e l y , those v i s i t s are m a i n -
l y of a f r i e n d l y n a t u r e . 
The drug behind the drama 
Fusion toxin 
'IL-2 receptors 
This illustration shows how fusion toxin 
therapy works. First, the diseased cell 
bearing IL-2 receptors welcomes the drug 
into its structure. Once inside the cell, the 
toxin separates from the IL-2 and destroys 
the cell. 
Perhaps m o r e i m p r e s s i v e t h a n 
t h e f u s i o n t o x i n i t s e l f is t h e 
t h e o r y b e h i n d t h e t h e r a p y . M u r -
p h y has shov^n t h a t p r o t e i n s a n d 
t o x i n s can be c o m b i n e d t o target 
speci f ic disease cel ls w h i l e spar-
i n g h e a l t h y cel ls . W i t h t h i s 
k n o w l e d g e , l a b o r a t o r y sc i e n t i s t s 
k n o w e x a c t l y h o w t h e d r u g w i l l 
act before t e s t i n g i t , w h i c h w i l l 
g r e a t l y h e l p i n t h e b ioengineer -
i n g , t o x i c i t y t e s t i n g , a n d t h e 
d e v e l o p m e n t of n e w drugs b y 
Seragen. 
" I n each i n s t a n c e w h e r e w e 
c o n s t r u c t e d a f u s i o n t o x i n , w e 
have k n o w n prec i se ly h o w t h a t 
p r o t e i n w o u l d act," says M u r p h y . 
" T h i s is v e r y e x c i t i n g . T h e I L - 2 
f u s i o n t o x i n is t h e f i r s t r a t i o n a l l y 
des igned t h e r a p e u t i c p r o t e i n ever 
tes ted i n m a n . I t is b r e a k i n g n e w 
g r o u n d , a n d i t is i n t h e f o r e f r o n t 
of b i o t e c h n o l o g y . " 
H e s k e t h agrees: " [ T h e f u s i o n -
t o x i n t h e r a p y ] is v e r y e x c i t i n g be-
cause i t is a t o t a l l y n e w concept . 
M o s t ' n e w ' concepts i n cancer 
t h e r a p y are a c t u a l l y n e w v a r i a -
t i o n s o n o l d approaches. For i n -
stance, c h e m o t h e r a p y can o n l y be 
so e f fec t ive , a n d t h e t o x i c i t y 
leve ls are g e n e r a l l y v e r y h i g h . 
T h i s is n o t t h e case w i t h t h i s 
t h e r a p y . So t h i s concept is v e r y 
e x c i t i n g a n d has a l o t of people 
v e r y c u r i o u s a b o u t i t s p o t e n t i a l . " 
D e s p i t e i t s success i n cancer 
cases s u c h as B i l l S m i t h ' s , M u r -
p h y feels t h a t t h e f u s i o n t o x i n 
t h e r a p y m a y h o l d m o r e p o t e n t i a l 
f o r a u t o i m m u n e diseases t h a n f o r 
cancer because of i t s a b i l i t y t o 
suppress t h e i m m u n e s y s t e m a n d 
k i l l diseased cel ls . C u r r e n t l y , 
f u s i o n t o x i n t h e r a p y is b e i n g 
b r o a d l y tes ted against a d u l t T - c e l l 
l y m p h o m a , as w e l l as o t h e r 
l e u k e m i a s a n d l y m p h o m a s w h i c h 
bear t h e I L - 2 receptor . H o w e v e r , 
t h e ear ly resu l t s of s tudies o n t h e 
t h e r a p y ' s use f o r m e t h o t r e x a t e -
res i s tan t r h e u m a t o i d a r t h r i t i s (at 
B e t h Israel H o s p i t a l i n Boston) 
a n d n e w - o n s e t T y p e I diabetes ( i n 
Paris, France) have been, as M u r -
p h y p u t i t , " s t r i k i n g . " 
A f t e r these i n v e s t i g a t i o n s , t h i s 
t h e r a p y w i l l have as i t s n e x t tar-
gets l u n g , breast a n d c o l o n can-
cer, t o be t r e a t e d w i t h t h e epider-
m a l g r o w t h fac to r (FGF) f u s i o n 
t o x i n ; m a l i g n a n t m e l a n o m a , t o be 
t r e a t e d w i t h t h e m e l a n o c y t e 
s t i m u l a t i n g h o r m o n e ( M S H ) 
f u s i o n t o x i n , a n d m u l t i p l e 
m y e l o m a s (cancer of t h e b o n e 
m a r r o w ) , t o be t r e a t e d w i t h t h e I L -
6 f u s i o n t o x i n . 
Some a u t o i m m u n e diseases 
t h a t also c o u l d b e n e f i t f r o m 
f u s i o n t o x i n t h e r a p y i n c l u d e i n -
f l a m m a t o r y b o w e l disease, m y a s -
t h e n i a gravis , l u p u s 
e r y t h e m a t o s u s , perhaps m u l t i p l e 
sclerosis, a n d m a y b e even A I D S . 
T h e issue w i t h A I D S is t h a t b o t h 
t h e H I V v i r u s a n d t h e f u s i o n 
t o x i n t h e r a p y suppress t h e i m -
m u n e s y s t e m , so t h e r e is a 
g e n u i n e c o n c e r n t h a t t h e t h e r a p y 
c o u l d a c t u a l l y m a k e A I D S w o r s e . 
" T h e r e m a y w e l l be some 
t h e r a p e u t i c b e n e f i t f o r A I D S , b u t 
t h e des ign of s u c h an i n v e s t i g a -
t i o n w o u l d have t o be v e r y care-
f u l l y p l a n n e d ; a n d t h a t w o u l d 
t a k e s o m e t i m e , " says M u r p h y . 
T h e t e r m s 'panacea' a n d 
' m a g i c b u l l e t ' ( cure -a l l f o r a l l d is -
eases) o f t e n are i n v o k e d w h e n 
t a l k i n g a b o u t n e w m e d i c a l 
b r e a k t h r o u g h s , s u c h as f u s i o n 
t o x i n t h e r a p y . W h i l e these are ex-
c i t i n g b u z z w o r d s , m o s t 
p h y s i c i a n s w i s h t h e y c o u l d be 
s t r i c k e n f r o m people 's 
vocabular ies . " I f one l o o k s at t h e 
t e c h n o l o g y [of f u s i o n t o x i n 
t h e r a p y ] , t h e p o t e n t i a l is over-
w h e l m i n g , " c o m m e n t s M u r p h y . 
"But t h e r e is so m u c h u n c e r t a i n t y 
because w e h a v e n ' t d e t e r m i n e d 
t h e l i m i t s of t h e t e c h n o l o g y . I n 
general , I d o n ' t be l i eve t h e r e w i l l 
ever be a s ingle agent t h a t w i l l 
success ful ly , b y i t se l f , t rea t a n y 
p a r t i c u l a r f o r m of cancer." 
Michael R. Paskavitz 
m FOR YOUR INFORM A TION 
Dr. Hesketh is 
c l inical director 
of the Evans 
Section of 
Medical 
Oncology at 
U H , and is an 
associate 
professor of medicine at Boston 
Universi ty School of Medicine. 
Dr. Murphy 
is chief of the 
Evans Section of 
Biomoleeular 
Medicine at the 
Hospital , and is 
a professor of 
medicine at the 
School of Medicine. 
If you w o u l d l ike more infor-
mat ion of fusion toxin therapy, 
or on medical oncology or 
biomoleeular medicine at U H , 
please call 1-800-842-3648 
during business hours. 
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Making Great Strides In Cancer Care 
A conversation with Humphrey Center Director 
Douglas V. Faller, M.D., Ph.D. 
Qet)A 
This past summer, Douglas V. Faller, M.D., 
Ph.D., was appointed as the new director of 
the Hubert H. Humphrey Cancer Center at 
Boston University Medical Center. In this 
position, Faller Is responsible for coordinat-
ing the overall cancer programs at Boston 
University Medical Center, which Includes 
both The University Hospital and Boston 
University School of Medicine. Faller 
comes to BUMC from the Dana Farber Can-
cer Institute. He received his under-
graduate degree from Massachusetts In-
stitute of Technology (MIT) and his medical 
degree from Harvard University. He also 
earned his doctorate from MIT, working in 
the areas of cancer viruses and cell biology 
under the direction of Nobel laureate David 
Baltimore. In an interview with Progress 
editor Michael Paskavitz, Faller talks about 
cancer research, his perceptions of cancer 
care, and his vision for the cancer center. 
Progress: It seems that cancer re-
search advanced a great deal through 
the 1980s, more so than i t had i n pre-
vious decades. If so, how has the new 
knowledge of cancer impacted the i n -
cidence of the disease? 
Faller: The incidence of cancer—the 
occurence rate—has not decreased 
dramatically. In fact, for some 
specific kinds of cancer, the oc-
curence rate is suhstantially higher 
today. The most s t r ik ing example of 
this is lung cancer i n w o m e n . Lung 
cancer i n men was v i r t u a l l y unheard 
of before smoking became popular. 
Lung cancer peaked i n males i n the 
19 70s and went down i n the 80s as 
fewer and fewer men smoked. O n 
the other hand, the occurence of new 
lung cancer i n w o m e n has greatly i n -
creased, and at this point is a more 
c o m m o n cause of cancer death i n 
w o m e n than even breast cancer. A n d 
this is because more and more 
w o m e n are smoking today. 
But w h i l e the incidence of a l l can-
cers has not changed, what has 
changed is our abi l i ty to treat and 
cure patients w i t h cancer. Ap-
proximately twice as many patients 
w i t h cancer are l i v i n g for at least f ive 
years than was the case 10 years ago. 
This is a very dramatic f inding. 
Even more dramatic, though, are 
the successes w i t h some specific can-
cers. For instance, we are now curing 
95 percent of children w i t h c o m m o n 
leukemia. We are curing an even 
higher percentage of children w i t h 
other types of tumors, and we are 
curing most patients w i t h Hodgkin's 
disease. 
I n addit ion, we are also now at a 
point where we can determine how 
m u c h treatment is enough, i n some 
cases, we are cut t ing hack and 
making our treatments more easy to 
accept on the part of the patient. We 
can decrease the amount of therapy 
we use and s t i l l get excellent results, 
i n the last year alone, there have been 
three very dramatic studies that have 
to ld us better ways of treating breast 
cancer, bowel cancer and rectal can-
cers, and these treatment strategies 
are a completely new way of looking 
at cancer. N o w , after surgery, even 
w h e n we t h i n k al l the disease has 
been removed, we treat pat ients— 
w h o normal ly w o u l d not have been 
treated i n the pas t—with 
chemotherapy. A n d this has had a 
tremendous impact on the cure rate 
of these malignancies, up to a t w o -
fold or three-fold improvement . 
There also has been a great deal of 
research going on to make treatment 
easier to tolerate for the patient, i n ad-
d i t i o n to decreasing the amount of 
therapy for patients. Studies have 
been ongoing to ut i l ize therapies 
other than surgery, or to use more 
conservative surgical methods that 
are less traumatic to the patient. The 
use of radiotherapy, w h i c h does not 
leave scars or disfigurement, has he-
come more common, and other new 
strategies are being used al l the t ime . 
In addition, even such things as 
the discomfort that people sometimes 
suffer w i t h chemotherapy, such as 
nausea and v o m i t i n g , are being ad-
dressed. Boston Univers i ty Medical 
Center, part icularly medical on-
cologist Dr. Paul Hesketh, has done a 
large and very successful study on On-
dansitron, w h i c h is a remarkable new 
drug that significantly decreases the 
amount of nausea and v o m i t i n g as-
sociated w i t h some types of 
chemotherapy, making i t completely 
disappear i n many patients. 
We've also recruited Dr. [James] 
Otis f r o m Sloan-Kettering Cancer 
Center i n N e w York to set up a pain , 
cl inic. Anesthesia and other depart-
ments have been heavily and success-
f u l l y involved i n taking care of 
patients w i t h pain i n the past. But 
Dr . Otis, a neurologist, is w o r k i n g i n -
dependently and w i t h ( U H Chief of 
Anesthesia) Dr . [Marcelle] W i l l o c k to 
develop a c l inic solely devoted to con-
t r o l l i n g pain i n patients, and not just 
cancer pain. 
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Progress: What's happening w i t h 
basic cancer research? 
Faller: The basic research on cancer 
i n the last 15 years, part icularly i n 
the last f ive years, has been extraor-
dinari ly productive. We have 
managed to discover, i n many cases, 
the causes of cancer—that is, the par-
t icular genes i n a cell that have gone 
awry and have led to development of 
malignancies. We do not k n o w every-
t h i n g ahout these genes yet, hut just 
f i n d i n g out w h i c h genes are abnormal 
gives us a tremendous advantage i n 
that we now can determine exactly 
what is different about a cancer cell 
as compared to a normal cell. A n d 
for the f irst t ime, we can start 
developing strategies designed to at-
tack the basic problem, the specific 
abnormali ty w i t h i n the cell, instead 
of using drugs or radiation therapy, 
w h i c h can damage al l cells i n the 
body. We now can pinpoint or target 
our therapy towards a particular gene 
or enzyme. This w o r k is extremely 
excit ing. A t the very basic level, 
these findings have not had major 
ramifications yet i n terms of 
therapeutics. But now that the tar-
gets have been identif ied, drug 
development aimed at these targets is 
progressing at a tremendous pace 
right now. In addit ion to having iden-
t i f ied the genes involved, i n many 
cases investigators are f inding other 
ways that t u m o r cells differ f r o m nor-
m a l cells and are a iming their therapy 
at that. For instance, here at the 
Medical Center, there is a very strong 
effort headed by ( U H chief of 
Biomoleeular Medicine) Dr . Jack 
M u r p h y to use fusion t o x i n therapy— 
that is, using monoclonal antibodies 
directed specifically at t u m o r cells to 
take a t o x i n and deliver i t direct ly to 
the tumor cells, sparing al l of the heal-
thy cells i n the body. This w o r k has 
been made possible,only by basic re-
search, w h i c h has al lowed us to iden-
t i f y new and specific proteins that we 
can use to target the monoclonal an-
tibodies. ( U H medical oncology 
chief) Dr . Ron McCaffrey's work , for 
instance, has been directed at those 
enzymes and those biochemical path-
ways specific for certain kinds of 
leukemia and tumor cells, and at 
developing new drugs that w i l l inter-
fere w i t h those pathways. In addi-
t i o n , the Center for H u m a n Genetics 
here at the Medical Center is making 
a strong effort directed toward i n -
herited cancers. We have been able 
to ident i fy a large number of 
chromosomal aberrations and 
markers that w i l l a l low people w h o 
are i n cancer-prone families to 
receive genetic counseling. It is i m -
portant to say here, though, that 
there are very few cancer-prone 
families, and we do not want people 
to be misled about this . 
'Basic research 
on cancer, 
especially i n 
the last five 
years, has been 
extraordinarily 
productive' 
Progress: What do the terms educa-
t i o n and prophylaxis mean i n terms 
of cancer? 
Faller: This is an important part of 
The Univers i ty Hospital 's cancer pro-
gram. A n d these are issues toward 
w h i c h The Univers i ty Hospita l and 
the Cancer Research Center are going 
to he directing a lot of their at tention. 
Early detection w i l l he addressed by 
developing screening examinations 
for the c o m m u n i t y , so people can 
come i n t o the Hospita l on an out-
patient basis and receive a number of 
tests to screen t h e m for the most 
c o m m o n kinds of treatable malignan-
cies. We anticipate that the 
Hospital 's new ambulatory center 
w i l l have a cancer screening day, 
through w h i c h patients can he tested 
for breast cancer, bowel and rectal 
cancer, uterine and cervical cancer, 
sk in cancer and lung cancer i n a very 
quick and efficient way. Many 
people no longer have doctors to 
w h o m they go for checkups on a 
regular basis, so rout ine health sur-
veys l ike this, w h i c h are designed to 
detect early-stage malignancies, are 
extremely useful. We also plan that 
the screening c l inic w i l l provide 
education to patients as to ho w they 
may change or improve their l i festyle 
to lower their r isk of cancer. 
Finally, The Univers i ty Hospital is 
going to be part ic ipating i n a very ex-
c i t ing study designed to prevent can-
cer. Drs. Maureen Kavanah and 
Marianne Front have long been 
providing care and counseling to 
w o m e n w h o are at h igh r isk for breast 
cancer. The Nat iona l Cancer In-
st i tute (NCI) has no w designed a 
study that w i l l a l low us to treat 
w o m e n prophylact ical ly w i t h a very 
safe and well-tolerated medicine. 
Our a i m is to see if we can prevent 
breast cancer i n w o m e n w h o are at 
high risk. This has never been done 
before. We are going to set up a high-
risk breast cancer screening and treat-
ment program w i t h i n the outpatient 
department. 
Progress: W i l l the cancer program he 
b u i l t around the Hospital 's research 
strengths? 
Faller: The cancer program's basic 
goal is to provide the best and most 
personal treatment that we can for a l l 
of the different kinds of malignancies, 
and I t h i n k we already do that very 
w e l l . We w i l l now he able to do that 
even better because the Hospital is 
c o m m i t t i n g itself to improved 
facilit ies and to bringing specialties 
and subspecialties in to a closer work-
ing relationship. We want to 
facilitate the way patients are seen, 
such as arranging so that they do 
have comprehensive cancer care al l 
around the Hospital . We w i l l central-
ize their care i n a dedicated fac i l i ty . 
We want to make the process of 
receiving care m u c h easier than i t is 
i n many other inst i tut ions . So the 
cornerstone, as i see i t , is a solid base 
of treatment designed for any type of 
malignancy. A n d because of the 
strong scientific and research efforts 
at the Hospital , we w i l l he able to 
bring new therapies on-l ine and in to 
c l inical trials, w h i c h w i l l make new 
treatments available to our patients. 
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T U U P Is BUDDING 
New minimal-access surgery may succeed TURP as 
'procedure of choice' for prostate removal 
f or hal f of a l l m e n over 50, i t ' s as inevi tab le as the greying of the i r hair tha t they w i l l suffer u n -comfor tab le u r i n a r y problems because of an 
enlarged prostate gland. Prior to 
W o r l d War I I , there was h u t one 
answer to such a p r o b l e m : open 
surgery to remove the prostate. 
T h e n along came t ransure thra l 
resect ion of the prostate (TURP), a 
less t r a u m a t i c surgery tha t has 
been used exc lus ive ly for the last 
40 years. Today, however , a poten-
t i a l successor to T U R P looms o n 
the h o r i z o n , one w h i c h promises 
pat ients better results, increased 
c o m f o r t , a shorter h o s p i t a l stay and 
less cost t h a n T U R P . 
Uro log is t s at T h e U n i v e r s i t y 
H o s p i t a l are inves t iga t ing t ran-
surethra l u l t rasound-guided laser i n -
duced pros ta tec tomy (TULIP) , a 
m i n i m a l l y invas ive procedure to 
remove an enlarged prostate g land 
that is o b s t r u c t i n g u r i n e f l o w . T h e 
procedure also is being s tudied at 
Lahey C l i n i c , B o w m a n Gray M e d i -
cal School, N o r t h M i s s i s s i p p i M e d i -
cal Center, Stanford U n i v e r s i t y and 
at univers i t i es i n N i j m e g e n , the 
Nether lands ; Herne , G e r m a n y ; and 
Paris, France. The T U L I P adds 
another capabi l i ty to the g r o w i n g 
l i s t of surgeries being per formed at 
T h e U n i v e r s i t y Hospi ta l ' s Center 
for M i n i m a l Access Surgery. 
" A l t h o u g h we 've done a relat ive-
l y s m a l l n u m b e r of procedures, the 
early results have been very en-
couraging," says R ichard K. 
Bahayan, M . D . , a U H uro logis t and 
a p r i n c i p l e invest igator of T U L I P . 
"We've seen a h i g h success rate 
w i t h no incidence of scarring or i n -
fection,- the operat ion takes a t h i r d 
of the t i m e of T U R P , and o n l y an 
HOW TUUP WORKS—The illustration below shows TOUP's four-step process. First, the 
halloon device Is Inserted Into the urethra. Step two Involves Inflating the halloon In the 
urethra. Step three requires visualizing the enlarged prostate with ultrasonic Imaging. And 
step four Involves the heating of the prostate tissue with laser energy. 
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overn igh t hospi ta l stay is needed. 
A n d the pat ients seem to be very 
satisfied postoperat ively . " 
How TULIP works 
A n enlarged prostate gland is a com-
m o n occurence i n m e n over the age 
of 50. W h e n n o r m a l , the chestnut-
sized prostate—located between 
the bladder and the u r e t h r a — 
mediates the f l o w of u r i n e f r o m the 
bladder and also provides a f l u i d 
necessary to semen p r o d u c t i o n . 
B u t w h e n the prostate becomes 
s w o l l e n , sometimes to the size of a 
grapefrui t , i t presses against the 
ure thra , causing u r i n a r y d i f f i c u l t i e s 
and also r i s k i n g damage to the k i d -
neys. 
T h e a b i l i t y to p e r f o r m T U L I P 
was made possible by c o m b i n i n g 
u l t r a s o u n d i m a g i n g w i t h laser tech-
nology, a capabi l i ty pioneered b y I n -
trasonix , Inc. , a B u r l i n g t o n , Mass. 
company . I t is the c l a r i t y of the 
u l t r a s o u n d image tha t a l lows the 
surgeon to direct the laser energy at 
the prostate w i t h p i n p o i n t accuracy. 
T h e T U L I P w o r k s by g u i d i n g the 
u l t r a s o u n d probe t h r o u g h the 
u r e t h r a to the prostate, and t h e n 
h e a t i n g the s w o l l e n prostate w i t h 
laser energy (see i l l u s t r a t i o n ) . A f t e r 
ahout three to six weeks, the pros-
tate t issue t y p i c a l l y sloughs off and 
is passed t h r o u g h u r i n e . 
Other options heing investigated 
T U L I P is n o t alone i n the race to 
succeed T U R P . Othe r approaches 
are being invest igated as w e l l : 
• M e d i c a t i o n s a t t e m p t to 
relax the constr i c ted neck of the 
prostate, w h i c h t h e n a l l o w s u r i n e 
to f l o w . A l p h a blockers, medica-
t ions used p r i m a r i l y for hyper ten-
s ion, successfully rel ieve 
s y m p t o m s i n 30 to 50 percent of 
cases. 
"However , " caut ions Bahayan, 
"these drugs are ind ica ted o n l y for 
selected pat ients w i t h smal ler pros-
tates that w i l l n o t b l o c k u r i n e f l o w 
once they become relaxed. A n d 
w h i l e w e are tes t ing several other 
medicat ions , the fact is tha t 
medica t ions i n general, especially i f 
t h e y are new, are very costly, and 
t h e y pose the threat of side effects." 
• Transure thra l i n c i s i o n of 
the prostate (TUIP), a v a r i a t i o n of 
T U R P , w o r k s by c u t t i n g the 
u r e t h r a l w a l l s a long the l e n g t h of 
the prostate, w h i c h a l l o w s the 
ure thra to expand and accom-
modate increased u r i n e f l o w . But 
Bahayan says that the use of T U I P 
is l i m i t e d because i t also is p r i m a r i -
l y ind ica ted for pat ients w i t h 
smal ler prostates. 
• Ba l loon d i l a t a t i o n w o r k s 
the same w a y as percutaneous hal-
l o o n angioplasty w o r k s for w i d e n -
i n g clogged coronary arteries. 
'We think the 
TULIP has the 
most promise 
hecause i t 
offers so many 
benefits' 
U n d e r local anesthesia, a t i n y hal -
l o o n attached to a catheter is 
guided i n t o the urethra , where i t is 
expanded to s tretch the prostate. 
"The major drawback to th i s ap-
proach," says Bahayan, "is tha t long-
t e r m results have n o t been 
measured. T h e theoret ica l con-
cern," he adds, "is tha t the ure thra 
c o u l d reconstr ic t to rehlock u r i n e 
f l o w , i n the same w a y tha t cer ta in 
coronary arteries reclog f o l l o w i n g 
angioplasty." 
• Heat therapy, or hyper-
t h e r m i a , w o r k s by heat ing the pros-
tate w i t h m i c r o w a v e energy, w h i c h 
k i l l s nerves i n the neck of the blad-
der and shr inks the prostate. " H y -
p e r t h e r m i a has got some p o t e n t i a l 
and we're l o o k i n g at some 
devices," states Bahayan. "But r i g h t 
n o w i t is a cost ly t rea tment w i t h 
no proven value." 
For n o w , Bahayan feels that 
T U L I P offers the most advantages: 
"We t h i n k the T U L I P is s h o w i n g 
the most promise because i t offers 
so m a n y benefits , n o t the least of 
w h i c h is less overa l l cost t h a n 
T U R P . O u r p r e l i m i n a r y data t e l l 
us tha t T U L I P has m o r e superior 
outcomes t h a n the other ap-
proaches. I n a d d i t i o n , i t is a proce-
dure tha t can he added f a i r l y easily 
to a doctor 's range of techniques." 
Questions ahout prostate surgery 
T h e p r i m a r y reason w h y so m a n y 
al ternat ives to T U R P are emerging 
is the federal government ' s concern 
w i t h cost c o n t a i n m e n t . Lach year, 
more t h a n 400,000 T U R P s are per-
f o r m e d (the m a j o r i t y i n the elderly 
Medicare popula t ion) at a t o t a l cost 
of ahout $4 b i l l i o n . A recent ar t ic le 
i n the Journal of the American 
Medical Association contended 
tha t as m a n y as 75 percent of 
T U R P s m a y he unnecessary, or at 
least lack absolute i n d i c a t i o n s for 
surgery. 
Bahayan says that w h i l e the ar-
t ic le , "raises some in teres t ing ques-
t ions , I believe those numbers are 
greatly in f la ted , and the authors 
drew some major conclusions o n 
quest ionable data. I t h i n k f u r t h e r 
s tudy is needed, and some prospec-
t i v e studies already are under w a y 
to l o o k at the efficacy of T U R P . " 
Of the n e w opt ions contending 
for the t i t l e of 'procedure-of-choice ' 
for prostate r e m o v a l , Bahayan says 
that i t ' s l i k e l y tha t no single proce-
dure w i l l preva i l the w a y T U R P 
has for 40 years. "Instead," he con-
cludes, "each procedure w i l l have 
i ts o w n ind ica t ions for i n d i v i d u a l 
cases. 
FOR YOUR INFORMA TION 
Dr. Babayan is a 
member of the 
Hospital's 
Department of 
Urology, and is 
a professor of 
urology at 
Boston 
Univers i ty School of Medicine. 
For more in format ion about 
the T U L I P procedure, urology 
services at U H , or the Center 
for M i n i m a l Access Surgery, 
please call 1-800-842-3648 
during business hours. 
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Back In The Swing Of Things 
New minimal-
access surgery 
for hernias gets 
patients on 
their feet 
quickly 
BY PATRICIA J. JACOBS 
F r a d i t i o n a l l y , a p a t i e n t w h o h a d surgery t o repair an i n g u i n a l her-n i a spent u p t o s ix w e e k s r e c o v e r i n g , w h i c h m e a n t t i m e 
a w a y f r o m w o r k , c o n s t a n t p a i n 
a n d v e r y l i m i t e d p h y s i c a l ac-
t i v i t y . T o d a y , h o w e v e r , a n e w ap-
p r o a c h t o h e r n i a repair b e i n g done 
at T h e U n i v e r s i t y H o s p i t a l ' s C e n -
ter f o r M i n i m a l Access S u r g e r y — 
laparoscopic h e r n i a repa i r—gets 
p a t i e n t s b a c k o n t h e i r feet as soon 
as t h e y leave t h e H o s p i t a l . 
A h e r n i a is d e f i n e d as a defect 
or weakness i n m u s c l e w a l l s or 
o t h e r t i ssue i n t h e b o d y . O n c e a 
h e r n i a is present , i t is a l m o s t i n -
e v i t a b l e t h a t i t w i l l r e q u i r e s u r g i -
ca l repair at some p o i n t . Each 
year, m o r e t h a n 500,000 
A m e r i c a n s u n d e r g o surgery t o 
repair i n g u i n a l hern ias , b y far t h e 
m o s t c o m m o n t y p e of h e r n i a . 
T h o u s a n d s m o r e deve lop hern ias 
t h a t w i l l e v e n t u a l l y need s u r g i c a l 
i n t e r v e n t i o n . 
Says L e o n Josephs, M . D . , a 
g a s t r o i n t e s t i n a l surgeon a n d t h e 
d i r e c t o r of U H ' s C e n t e r for M i n i -
m a l Access Surgery, " W h i l e these 
hern ias can be m e r e l y a n n o y i n g 
f o r m a n y years, i f a piece of i n t e s -
t i n e becomes t r a p p e d i n t h e 
w e a k e n e d h e r n i a area a n d cuts of f 
t h e b l o o d s u p p l y , t h e y can be-
c o m e l i f e - t h r e a t e n i n g a n d can re-
q u i r e e m e r g e n c y measures . " 
New technology, methodology 
T r a d i t i o n a l i n g u i n a l h e r n i a repair 
has r e q u i r e d o p e n surgery , w h i c h 
m e a n s t h a t a surgeon c u t s 
t h r o u g h m a n y layers of t i s sue i n 
t h e a b d o m i n a l w a l l t o reach t h e 
s i te of t h e h e r n i a . T h e n , after 
r e p a i r i n g t h e w e a k e n e d area, 
w h e t h e r b y s t i t c h i n g i t t o g e t h e r 
or b y i n s e r t i n g a m e s h prosthes is , 
t h e surgeon m u s t close a l l those 
layers of t i ssue . Because t h e ad-
hes ions a n d s c a r r i n g of t h e t i ssue 
a n d m u s c l e m u s t hea l , r e c o v e r y 
t i m e can t a k e m a n y w e e k s . 
"Severe r e s t r i c t i o n of p h y s i c a l 
a c t i v i t y has been p a r t of t h e 
recovery , " says Josephs. " T h a t 
m e a n s people w h o r e q u i r e p h y s i -
ca l s t r e n g t h o n t h e job can ' t go 
b a c k t o w o r k for u p t o s ix w e e k s . 
A n d c e r t a i n l y a l l a t h l e t i c a c t i v i t y 
m u s t s top for at least t h a t l o n g . " 
T h e laparoscopic p r o c e d u r e is 
less i n v o l v e d , requires s h o r t e r 
o p e r a t i n g r o o m t i m e a n d causes 
m i n i m a l s c a r r i n g t o t h e t i s sue sur-
r o u n d i n g t h e h e r n i a . T h e laparo-
scope is a s u r g i c a l scope w i t h a 
s m a l l camera o n i t s t i p . D u r i n g 
surgery, t h e laparoscope is g u i d e d 
t o t h e s i te of t h e surgery t h r o u g h 
one of t h r e e h a l f - i n c h i n c i s i o n s 
m a d e i n t h e a b d o m e n . 
O n c e placed at t h e s u r g i c a l 
s i te , t h e scope v i s u a l i z e s t h e 
surgery w i t h great c l a r i t y o n a 
t e l e v i s i o n m o n i t o r above t h e 
o p e r a t i n g table , a n d t h e surgeon 
w o r k s b y v i e w i n g t h e procedure . 
T h e surgeon t h e n repairs t h e her-
n i a w i t h i n s t r u m e n t s i n s e r t e d 
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t h r o u g h t h e t w o o t h e r i n c i s i o n s , 
aga in e i t h e r b y d o s i n g t h e defect 
or a t t a c h i n g a m e s h prosthes is t o 
i t . I n b o t h eases, a d d i t i o n a l 
damage t o t i ssue s u r r o u n d i n g t h e 
h e r n i a is g r e a t l y reduced . 
T h e laparoscope has been used 
b y gyneeoiog is t s f o r m a n y years 
for d iagnosis a n d surgery, a n d i n 
t h e last several years b y 
g a s t r o i n t e s t i n a l surgeons t o 
r e m o v e ga i ib iadders a n d 
gal l s tones . By i t s n a t u r e , laparo-
scopic surgery is a n e w o r i e n t a -
t i o n for surgeons, r e q u i r i n g great 
hand-eye c o o r d i n a t i o n . 
Laparoscopic repair of i n g u i n a l 
h e r n i a s is o f fe red o n l y at a h a n d -
f u l of m e d i c a l centers t h r o u g h o u t 
t h e c o u n t r y . H o w e v e r , a c c o r d i n g 
t o Josephs, t h e laparoscope m a y 
r e v o l u t i o n i z e h e r n i a surgery . I t s 
t r e m e n d o u s b e n e f i t s w i i i i i k e i y 
set of f a g r o u n d s w e i i of t r a i n i n g 
for surgeons t o use t h i s a p p r o a c h . 
A f t e r t h e laparoscopic proce-
dure , t h e p a t i e n t u s u a l l y can 
r e s u m e n o r m a l a c t i v i t i e s , i n c l u d -
i n g sports a c t i v i t i e s , a l m o s t i m -
m e d i a t e l y . " M y p a t i e n t s have 
gone b a c k t o m a n u a l labor jobs 
a n d b a c k t o sports w i t h i n several 
days," notes Joseph. I n a d d i t i o n , 
iaparoseopie surgery reduces t h e 
r i s k of p o s t - o p e r a t i v e i n f e c t i o n , 
w h i c h m a y i m p r o v e r e c u p e r a t i o n . 
M a n y people w i t h hern ias 
de lay surgery u n t i l t h e h e r n i a 
reaches a cr is i s stage. Josephs 
says t h a t t h e b e n e f i t s of t h i s n e w 
p r o c e d u r e s h o u l d encourage her-
n i a sufferers t o have p r e v e n t i v e 
surgery r a t h e r t h a n w a i t i n g u n t i l 
an e m e r g e n c y s i t u a t i o n forces 
t h e m t o seek t r e a t m e n t . 
"Because i t takes s u c h a t i m e 
c o m m i t m e n t t o have t h e open 
surgery, m a n y p a t i e n t s w i t h i n -
g u i n a l he rn ias have de layed 
h a v i n g a h e r n i a repair for m a n y 
years," says Josephs. " H o w e v e r , i t 
is i n e v i t a b l e t h a t a h e r n i a w i l l 
need t o be repaired, a n d d o i n g so 
sooner r a t h e r t h a n la ter can 
p r e v e n t p a i n a n d a possible l i f e -
t h r e a t e n i n g emergency . " 
A viable entity 
Laparoscopic h e r n i a repair repre-
sents y e t a n o t h e r c a p a b i l i t y i n 
t h e g r o w i n g f i e l d of m i n i m a l - a e -
eess surgery, an i n n o v a t i v e dis-
c i p l i n e i n w h i c h surgeons seek 
n e w approaches t h a t are m i n i m a l -
l y i n v a s i v e a n d less t r a u m a t i c t o 
p a t i e n t s t h a n t r a d i t i o n a l 
surgeries . These surgeries t y p i c a l -
l y of fer a q u i c k r e c o v e r y for t h e 
p a t i e n t a n d less cost for t h e payer . 
T h e i m p e t u s for f o u n d i n g t h e 
C e n t e r for M i n i m a l Access 
Surgery arose f r o m t h e t r e m e n -
dous success of iaparoseopie 
e h o i e e y s t e e t o m y for g a l l b l a d d e r 
r e m o v a l , w h i c h was p e r f o r m e d 
f o r t h e f i r s t t i m e i n B o s t o n b y 
D e s m o n d H . B i r k e t t , M . D . , ch ie f 
of t h e U H Sec t ion of G a s t r o i n t e s -
t i n a l Surgery. 
I n t h e C e n t e r ' s m i n i m a l - a c c e s s 
research l a b o r a t o r y , Josephs, 
B i r k e t t a n d o t h e r U H surgeons 
are i n v e s t i g a t i n g n e w m i n i m a l - a c -
cess t e c h n i q u e s a n d s u r g i c a l i n -
s t r u m e n t a t i o n . R i c h a r d K. 
Babayan, M . D . , a U H u r o l o g i s t , is 
t e s t i n g a n e w m i n i m a i - a e e e s s p r o -
cedure for t h e r e m o v a l of an en-
larged pros ta te g l a n d (see s tory , 
page 6). A c c o r d i n g t o Josephs, 
m i n i m a i - a e e e s s surgery for u lcers 
( v a g o t o m y ) , i n t e s t i n e s a n d for 
o t h e r types of hern ias s h o u l d 
b e g i n w i t h i n t h e n e x t several 
m o n t h s . 
• FOR YOUR INFORMA TION 
Dr. Josephs is 
director of the 
U H Center for 
M i n i m a l Access 
Surgery, and is 
an assistant 
professor of 
surgery at 
Boston Univers i ty School of 
Medicine. 
If you w o u l d l ike more infor-
mat ion on laparoscopic hernia 
repair, or other minimal-access 
procedures, please call 1-800-
842-3648 during business hours. 
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A THERECTOMY: 
LIKE A ROTO-ROOTER 
New percutaneous treatment for 
coronary artery disease 
o w t h a t hear t 
specia l is ts have be-
c o m e p r o f i c i e n t at 
r e l i e v i n g b l o c k e d 
c o r o n a r y arter ies 
t h r o u g h bypass 
surgery , b a l l o o n a n g i o p l a s t y a n d 
m e d i c a t i o n s , t h e i r n e w charge is 
t o f u r t h e r per fec t those t e c h n i -
ques a n d devise n e w strategies 
t h a t are even m o r e e f fec t ive . 
W h i l e a n g i o p l a s t y has p r o d u c e d 
d r a m a t i c resu l t s i n r e l i e v i n g 
s y m p t o m s of c o r o n a r y a r t e r y dis-
ease, i t s l o n g - t e r m effects are 
l i m i t e d b y restenosis , a reb ioek-
i n g of t h e a r t e r y at t h e s i te of t h e 
a n g i o p l a s t y , w h i c h occurs i n 30 
t o 40 percent of p a t i e n t s . 
R e c e n t l y , several n e w per-
c u t a n e o u s devices have been i n -
t r o d u c e d i n a n e f f o r t t o o v e r c o m e 
these l i m i t a t i o n s . O n e s u c h t e c h -
n i q u e , c o r o n a r y a t h e r e c t o m y , 
n o w b e i n g done r o u t i n e l y b y car-
d i o l o g i s t s at T h e U n i v e r s i t y 
H o s p i t a l , takes a v i r t u a l " r o t o -
r o o t e r " approach t o d e a l i n g w i t h 
c logged c o r o n a r y arter ies b y shav-
i n g f a t t y deposi ts of f t h e a r t e r i a l 
w a l l s (see i l l u s t r a t i o n ) . I n t h e 
shor t r u n , i t m a y p r o v e t o be e v e n 
m o r e b e n e f i c i a l t o se lected 
p a t i e n t s t h a n b a l l o o n a n g i o p l a s t y . 
B a l l o o n a n g i o p l a s t y a n d 
c o r o n a r y a t h e r e c t o m y are n o n -
opera t ive i n t e r v e n t i o n proce-
dures, w h i c h increase t h e b l o o d 
f l o w i n c o r o n a r y arteries t h a t 
have b e c o m e b l o c k e d b y f a t t y 
deposi ts i n t h e a r t e r y w a l l s . B o t h 
procedures are p e r f o r m e d w i t h a 
success rate of m o r e t h a n 90 per-
cent , a n d b o t h spare p a t i e n t s t h e 
t r a u m a of t r a d i t i o n a l bypass 
surgery a n d a l e n g t h y h o s p i t a l i z a -
t i o n a n d r e c o v e r y p e r i o d . 
M e m b e r s of U H ' s Sec t ion of 
C a r d i o l o g y have e m b a r k e d w i t h 
25 o t h e r i n s t i t u t i o n s o n a n 18-
m o n t h i n v e s t i g a t i o n a i m e d at 
c o m p a r i n g c o r o n a r y a t h e r e c t o m y 
t o c o r o n a r y b a l l o o n a n g i o p l a s t y . 
With atherectomy, a balloon with a cutting 
device is guided to the site of the bloclr-
age, where the plaque Is shaved off the 
arterial wall. The result 
Is an artery that Is only 0 to 
10 percent blocked. 
Coronary artery 
70-80°0 blocked 
By s t u d y i n g p a t i e n t s w h o have u n -
dergone e i t h e r procedure , re-
searchers h o p e t o d e t e r m i n e 
w h i c h of t h e t w o t e c h n i q u e s best 
reduces t h e i n c i d e n c e of res-
tenos is . 
" A l t h o u g h b a l l o o n a n g i o p l a s t y 
has r e v o l u t i o n i z e d t h e t r e a t m e n t 
of o b s t r u c t i v e c o r o n a r y disease, 
i t s m a j o r l i m i t a t i o n r e m a i n s a 
c o n s t a n t a n d f a i r l y h i g h i n c i d e n c e 
of restenosis , " says A l i c e Jacobs, 
M . D . , d i r e c t o r of t h e Card iac 
C a t h e r i z a t i o n L a b o r a t o r y a n d t h e 
p r i n c i p a l i n v e s t i g a t o r at U H i n 
t h e m u i t i e e n t e r s t u d y . "Res-
tenos is is n o t a e o m p i i e a t i o n of 
e i t h e r a n g i o p l a s t y or atherec-
t o m y , b u t r a t h e r i t is s o m e t h i n g 
t h a t a p a t i e n t accepts as a l i m i t a -
t i o n of those procedures . " 
To remodel or remove 
W h i l e t h e t w o t e c h n i q u e s ach ieve 
t h e same o b j e c t i v e — w i d e n i n g t h e 
v e s s e l — t h e i r m e t h o d s are q u i t e 
d i f f e r e n t . B a l l o o n a n g i o p l a s t y i n -
v o l v e s t h e i n s e r t i o n of a b a l l o o n -
t i p p e d ca theter i n t o t h e f e m o r a l 
a r t e r y i n t h e g r o i n , g u i d i n g t h e 
ca theter t o t h e diseased p o r t i o n of 
t h e a r t e r y a n d i n f l a t i n g t h e b a i -
X 
Post-angioplasty 
20-30°a blocked 
Post-atherectomy 
0-10°'o blocked 
\ 
i 
10 T H E U N I V E R S I T Y H O S P I T A L 
l o o n . T h e b a l l o o n presses t h e 
f a t t y deposi ts against t h e a r t e r y 
w a i l , t h u s w i d e n i n g t h e vessel . 
A t h e r e c t o m y i n v o l v e s t h e c u t -
t i n g a n d a c t u a l r e m o v a l of f a t t y 
deposi ts f r o m t h e a r t e r y w a l l . A s 
w i t h a n g i o p l a s t y , t h i s p r o c e d u r e 
uses a catheter , b u t also uses a 
c u t t i n g device . W h e n a s m a l l ba l -
l o o n is i n f l a t e d at l o w pressure, 
t h e c u t t e r is pressed against t h e 
a r t e r y w a i l a n d is a c t i v a t e d u s i n g 
a h a n d - h e l d m o t o r , w h i c h shaves 
of f t h e p laque . T h e shavings are 
t h e n c o l l e c t e d i n t h e nosecone of 
t h e catheter . "So u n l i k e an-
g i o p l a s t y , a t h e r e c t o m y i n v o l v e s 
t h e r e m o v a l — r a t h e r t h a n t h e 
r e m o d e l i n g — o f f a t t y depos i t s , " 
Jacobs notes . 
W h i l e a n g i o p l a s t y c o n t i n u e s t o 
be a t r e a t m e n t of c h o i c e f o r cer-
t a i n c o r o n a r y p a t i e n t s , a r e l a t i v e -
l y h i g h i n c i d e n c e of restenosis 
a n d a b r u p t vessel c losure r e m a i n 
p r o b l e m a t i c . T h e s u d d e n c losure 
of a vessel occurs i n some f i v e t o 
10 p e r c e n t of a n g i o p l a s t y 
p a t i e n t s , a n d is b e l i e v e d t o be re-
l a t e d t o t h r o m b o s i s (the f o r m a -
t i o n of b l o o d c lo ts i n t h e vessel) 
or t o t h e d i s s e c t i o n of t h e a r t e r y 
w a i l . I n e i t h e r case, e m e r g e n c y 
bypass surgery o f t e n is needed i f 
t h e vessel c a n n o t be reopened. 
I n a d d i t i o n , a t h e r e c t o m y is 
sa id t o leave an a r t e r y t h a t is 
o n l y zero t o 10 p e r c e n t b l o c k e d 
f o l l o w i n g t h e p r o c e d u r e , w h i l e 
a n g i o p l a s t y leaves a b o u t a 20 t o 
30 percent b lockage . Because 
a t h e r e c t o m y presents a larger 
a r t e r y o p e n i n g a n d t h e r e is less 
chance for vessel i n j u r y , experts 
f e e l t h a t i t m a y be m o r e success-
f u l a t r e d u c i n g restenosis . 
" T h e r e is p r e l i m i n a r y data sug-
g e s t i n g t h a t a t h e r e c t o m y m a y 
reduce t h e i n c i d e n c e of res-
tenos is i n c e r t a i n cases, b u t f u r -
t h e r e v a l u a t i o n is needed," Jacobs 
notes . " A n g i o p l a s t y a n d atherec-
t o m y b o t h i n j u r e t h e ar tery ; a n d 
s ince res tenos is is i n p a r t a 
response t o i n j u r y , i t is l i k e l y 
t h a t a t h e r e c t o m y w i i i see some 
i n c i d e n c e of restenosis . " 
T h e d e c i s i o n t o o p t f o r an-
g i o p l a s t y or a t h e r e c t o m y n o r m a l -
l y is m a d e af ter a p a t i e n t has 
f a i l e d t o r e s p o n d t o m e d i c a t i o n , 
a n d u p o n d e t e r m i n i n g t h e e x t e n t 
of t h e diseased ar te ry . For i n -
stance, e x p l a i n s Jacobs, t h e best 
a p p r o a c h f o r a p a t i e n t w h o s e 
Treliminary 
data suggest 
that coronary 
atherectomy 
may reduce 
restenosis i n 
certain cases' 
a r t e r y has been bloclced c o m p l e t e -
l y f o r t h r e e m o n t h s or longer is 
f u l i - b i o w n bypass surgery . H o w -
ever, as she notes , " I f y o u ' r e a can-
d i d a t e for a n g i o p l a s t y , t h e n y o u 
m a y be a c a n d i d a t e f o r atherec-
t o m y as w e l l . A t t h a t p o i n t , w e 
w o u l d l o o k at t h e charac te r i s t i c s 
of t h e b l o c k a g e t o d e t e r m i n e 
w h i c h p r o c e d u r e is best ." 
Some blockages have clear i n -
d i c a t i o n s f o r one p r o c e d u r e or t h e 
o t h e r . For ins tance , p a t i e n t s 
w i t h b lockages at t h e o r i g i n of 
t h e a r t e r y or o n one side of t h e 
a r t e r y m a y be b e t t e r t r e a t e d w i t h 
a t h e r e c t o m y . O n t h e o t h e r h a n d , 
p a t i e n t s w i t h les ions i n h e a v i l y 
c a l c i f i e d or s m a l l e r vessels are 
best s u i t e d f o r a n g i o p l a s t y . 
Making strides in diagnosis 
T w o n e w technolog ies , i n t r a v a s -
c u l a r u l t r a s o u n d a n d angioscopy, 
have e n h a n c e d t h e diagnosis of 
hear t disease i n U H p a t i e n t s . 
I n t r a v a s c u l a r u l t r a s o u n d , 
w h i c h can be used i n c o n j u n c t i o n 
w i t h a n g i o p l a s t y or a t h e r e c t o m y , 
enables c a r d i o l o g i s t s t o g u i d e t h e 
b a l l o o n - t i p p e d c a t h e t e r — e q u i p -
ped w i t h an e c h o t r a n s d u c e r — i n 
place w h i l e a c t u a l l y v i s u a l i z i n g 
t h e a r t e r y a n d prec i se ly l o c a t i n g 
t h e b lockage or l e s i o n . T h e 
t e c h n o l o g y also is capable of detect-
i n g early-stage les ions of 
ar ter iosc leros is be t te r t h a n t r a d i -
t i o n a l ang iography , an x - r a y ex-
a m i n a t i o n of t h e b l o o d vessels. 
A n g i o s c o p y also p r o v i d e s an ac-
c u r a t e assessment of c o r o n a r y 
h e a r t disease b o t h before a n d 
after a n g i o p l a s t y or a t h e r e c t o m y . 
A n g i o s c o p y , w h i c h presents a n ac-
t u a l p h o t o g r a p h of t h e vessel, 
m a y be m o s t b e n e f i c i a l i n t h e 
e v a l u a t i o n of p a t i e n t s w h o are u n -
d e r g o i n g a n g i o p l a s t y a n d w h o are 
e x p e r i e n c i n g c o m p l i c a t i o n s , s u c h 
as a b r u p t vessel c losure , s ince 
t h r o m b o s i s or d i s s e c t i o n f laps 
m a y be d i r e c t l y v i s u a l i z e d . 
B o t h t e c h n o l o g i e s of fer c e r t a i n 
benef i t s . " I n s o m e w a y s , i n t r a v a s -
c u l a r u l t r a s o u n d is m u c h m o r e 
s e n s i t i v e t h a n angiography . For 
ins tance , y o u m i g h t l o o k at an an-
g i o g r a m a n d see t h a t a p a t i e n t has 
n o s i g n i f i c a n t c o r o n a r y disease. 
H o w e v e r , w h e n y o u use i n t r a v a s -
c u l a r u l t r a s o u n d , y o u can see t h a t 
t h e r e is ev idence of ear ly p l a q u e 
f o r m a t i o n , " says Jacobs. 
Cynthia L. Lepore 
FOR YOUR INFORMA TION 
Dr. Jacobs is a 
member of the 
Evans Section 
of Cardiology at 
U H , and is an 
associate 
professor o f 
medicine at 
Boston Universi ty School of 
Medicine. 
If y o u w o u l d l ike more infor-
mation on coronary atherec-
tomy or on cardiology services 
at u i - l , please call 1-800-842-
3648 during business hours. 
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IfsMy 
Birthmark 
...I Was 
Bom 
With If 
Laser removes 
portwine stains, 
and erases a 
painfui stigma 
BY C Y N T H I A L . LEPORE 
Mi c h a e l G e l i n e a u , a second-grader at t h e F i rs t L u t h e r a n School i n H o i y o k e , Mass . , is w h a t y o u m i g h t 
c a l l y o u r t y p i c a l seven y e a r - o l d 
b o y : H e is pass ionate a b o u t 
M i c h a e l Jordan a n d t h e Teenage 
M u t a n t N i n j a T u r t l e s , a n d , at 
t i m e s , he t h i n k s t h a t h i s 10-year-
o i d s ister can be a b i t overbear-
i n g . Y e t w h i l e M i c h a e l G e l i n e a u 
has in te res t s s i m i l a r t o those h i s 
age, he is i n h e r e n t l y d i f f e r e n t . 
M i c h a e l was b o r n t w o m o n t h s 
p r e m a t u r e , w e i g h i n g b u t 2 
p o u n d s a n d 13 ounces . I n a d d i -
t i o n t o h a v i n g a h o s t of m e d i c a l 
c o m p l i c a t i o n s , m a n y of t h e m l i f e -
t h r e a t e n i n g , he also was a f f l i c t e d 
w i t h a p o r t w i n e s t a i n (a p u r p l e 
b i r t h m a r k ) t h a t covered t h e r i g h t 
side of h i s face. I n i t i a l l y , t h e 
m a r k was n o t a m a j o r c o n c e r n for 
M i c h a e l ' s parents , Jeanne a n d 
Bob. B u t as t h e i r son g r e w a n d 
t h e m a r k became m o r e apparent , 
t h e G e i i n e a u s s o u g h t t r e a t m e n t 
f o r fear t h a t t h e scar d i s f i g u r i n g 
M i c h a e l ' s face m i g h t s o m e d a y be-
c o m e a p s y c h o l o g i c a l scar as w e l l . 
" O r i g i n a l l y , a i l t h e doc tors 
t a l k e d a b o u t was c o v e r i n g u p t h e 
m a r k . T h e y t o l d us i t was g o i n g 
t o be there forever . W e w e r e 
Thanks to his laser treatments at UH, 
seven-year-old Michael Gelineau has seen 
his disfiguring portwine stain be almost 
completely erased. 
h o p i n g s o m e f o r m of t r e a t m e n t 
was o u t t h e r e t o h e l p M i c h a e l , " 
says Jeanne G e l i n e a u . 
I n 1988, t h e G e i i n e a u s w e r e 
re fer red t o Barbara G i l c h r e s t , 
M . D . , d i r e c t o r of t h e D e r m a t o l -
ogy Laser Genter a n d chie f of t h e 
D e p a r t m e n t of D e r m a t o l o g y at 
T h e U n i v e r s i t y H o s p i t a l , w h e r e 
researchers h a d m a d e s i g n i f i c a n t 
a d v a n c e m e n t s i n t r e a t i n g 
c h i l d r e n w i t h p o r t w i n e stains . 
T h i s m e d i c a l b r e a k t h r o u g h , as i t 
t u r n e d o u t , i n v o l v e d t h e use of a 
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p u l s e d t u n a b l e dye laser t o "zap" 
t h e p o r t w i n e s ta ins . T h e m a r k s 
r e s u l t f r o m a m a l f o r m a t i o n of 
b l o o d vessels near t h e surface of 
s k i n , o f t e n o n t h e face a n d n e c k . 
T h e y o c c u r i n a b o u t t h r e e o u t of 
1,000 c h i l d r e n . 
T h e laser t r e a t m e n t , w h i c h 
w a s p i o n e e r e d at U H , is n o w 
b e i n g p e r f o r m e d r o u t i n e l y i n t h e 
n e w l y r e n o v a t e d Laser Ce nte r , as 
w e l l as at m a n y large t e a c h i n g 
h o s p i t a l s t h r o u g h o u t t h e U n i t e d 
States. L x t e n s i v e exper ience 
s h o w s t h a t i t safely a n d per-
m a n e n t l y erases p o r t w i n e s ta ins . 
How the laser works 
L i k e m o s t laser p a t i e n t s , M i c h a e l 
G e l i n e a u receives h i s t r e a t m e n t s 
every t w o t o t h r e e m o n t h s . W i t h 
14 t r e a t m e n t s b e h i n d h i m , h i s 
b i r t h m a r k is a b o u t 80-percent 
erased. A l t h o u g h t h e procedure 
lasts o n l y a b o u t 15 m i n u t e s , t h e 
G e i i n e a u s m u s t a r r i v e at least an 
h o u r p r i o r t o M i c h a e l ' s a p p o i n t -
m e n t . T h e nurse f i r s t rubs a t o p i -
ca l a n e s t h e t i c o i n t m e n t o n 
M i c h a e l ' s face t o n u m b t h e af-
f e c t e d area a n d a d m i n i s t e r s a l i q -
u i d m e d i c a t i o n t h a t m a k e s h i m 
feel d r o w s y . 
U s i n g w h a t l o o k s l i k e a f a i r y ' s 
w a n d , G i l c h r e s t operates t h e 
laser, repea ted ly i r r a d i a t i n g s m a l l 
c i rc les of p u r p l i s h - r e d s k i n o n 
M i c h a e l ' s face. T h e e m i t t e d y e l -
l o w laser l i g h t is c o m p l e m e n t a r y 
i n c o l o r t o t h e r e d h e m o g l o b i n i n -
side t h e enlarged p o r t w i n e s t a i n 
vessels. T h e l i g h t is s e l e c t i v e l y 
ahsorbed h y t h e r e d p i g m e n t , 
g e n e r a t i n g in tense l o c a l heat t h a t 
des t roys t h e h i o o d vessels h u t 
spares s u r r o u n d i n g n o r m a l s t ruc -
t u r e s i n t h e s k i n . For t h e p a t i e n t , 
t h i s creates a n i n s t a n t sensat ion 
c o m p a r e d h y some t o a needle 
p r i c k or t h e s n a p p i n g of a r u h b e r 
h a n d , i m m e d i a t e l y f o l l o w e d b y a 
b i a c k - a n d - h i u e d i s c o l o r a t i o n of 
t h e s k i n w h e r e t h e vessels r u p -
t u r e . T h i s b r u i s e t h e n fades over 
seven t o 10 days w h i l e t h e s k i n 
creates n e w b l o o d vessels, m o r e 
n o r m a l i n size a n d b l o o d c o n t e n t 
t h a n t h e p o r t w i n e vessels. I m -
p r o v e m e n t s i n s k i n c o l o r are 
v i s i b l e af ter o n l y one t r e a t m e n t 
session, a l t h o u g h m u l t i p l e t rea t -
m e n t s — a t least s ix t o e i g h t — a r e 
needed before s k i n c o l o r r e t u r n s 
t o n o r m a l . 
" A t a t h e o r e t i c a l l e v e l , I t h i n k 
t h e appeal of t h e laser is t h a t i t is 
t e c h n i c a l l y v e r y e legant , " says 
G i l c h r e s t . " O n e uses t h e u n i q u e 
p r o p e r t i e s of laser l i g h t t o seek 
o u t a s i n g l e - c o l o r e d target w i t h i n 
a c o m p l e x t i s s u e — t h e d i l a t e d 
b l o o d vessels t h a t c o n t a i n 
h e m o g i o h i n — a n d t o s e l e c t i v e l y 
d e s t r o y t h a t target w i t h o u t h a r m -
i n g or a l t e r i n g t h e s u r r o u n d i n g 
s k i n . T h a t ' s w h y t h e resul t s of 
t h i s t r e a t m e n t are so successful . " 
'Pepperoni face' 
A l t h o u g h a p o r t w i n e s t a i n is n o t 
l i f e - t h r e a t e n i n g , i t s s t i g m a can he 
p s y c h o l o g i c a l l y d e s t r u c t i v e . 
M i c h a e l G e l i n e a u k n o w s w h a t i t 
feels l i k e t o he j a u n t e d h y h i s 
peers, h a v i n g been c a l l e d 'Pep-
p e r o n i face ' o n n u m e r o u s oc-
casions. " I d o n ' t l i k e i t . I used t o 
get t i r e d of i t . N o w I t e l l t h e m 
' I t ' s m y b i r t h m a r k a n d I w a s h o r n 
w i t h i t , ' " he says. 
L v e n h i s parents a n d h i s o lder 
sister, A l i s o n , age 10, have h a d t o 
deal w i t h t h e s t i g m a . "People ask 
m e w h a t ' s w r o n g w i t h m y 
b r o t h e r a n d I j u s t t e l l t h e m t h a t 
t h a t ' s t h e w a y he w a s b o r n , " says 
A l i s o n . 
" W h a t I f i n d m o s t i m p r e s s i v e 
i n s p e a k i n g w i t h f a m i l i e s of 
c h i l d r e n w i t h p o r t w i n e s ta ins , " 
says G i l c h r e s t , "is h o w f r o m i n -
f a n c y these c h i l d r e n a n d t h e i r 
f a m i l i e s are repeatedly asked 
' W h a t ' s w r o n g w i t h you? W h a t 
h a p p e n e d t o you? D i d y o u fail? 
D i d y o u get h i t ? ' G h i i d r e n he-
c o m e aware at a v e r y y o u n g age 
t h a t t h e y are d i f f e r e n t a n d t h a t 
there 's s o m e t h i n g w r o n g w i t h 
t h e m . I t c e r t a i n l y i n f l u e n c e s h o w 
t h e y see t h e m s e l v e s , " she adds. 
T o c o u n t e r t h e soc ie ta l i m p a c t 
of M i c h a e l ' s b i r t h m a r k , M r s . 
G e l i n e a u says she a n d her h u s -
b a n d a l w a y s have m a d e i t a p o i n t 
t o t rea t t h e i r son w i t h t h e u t m o s t 
n o r m a l c y . Says Boh G e l i n e a u , 
" M i c h a e l ' s a s t r o n g l i t t l e g u y . 
He ' s never l e t h i s s t a i n i n t e r f e r e 
w i t h t h e w a y he relates t o people . " 
Pediatric anesthesia nowavailahle 
W h i l e t h e laser t r e a t m e n t 
produces d r a m a t i c resu l t s i n b o t h 
c h i l d r e n a n d a d u l t s , t h e d i s c o m -
f o r t associated w i t h t h e t reat -
m e n t is c o m m o n t o a i l age 
groups . M o s t adul t s t o l e r a t e t h e 
t r e a t m e n t q u i t e w e l l , h u t t h e p r o -
cedure is s o m e t i m e s unbea ra b le 
t o s m a l l c h i l d r e n . 
T o a l l e v i a t e t h e d i s c o m f o r t i n 
c h i l d r e n , t h e U H Laser Genter , i n 
c o n j u n c t i o n w i t h t h e D e p a r m e n t 
of A n e s t h e s i o l o g y , n o w offers a 
p e d i a t r i c anesthesia service as a n 
a d j u n c t t o c o n v e n t i o n a l m e t h o d s 
of sedat ion . T h e service i n v o l v e s 
an i n t r a v e n o u s a d m i n i s t r a t i o n of 
a v e r y s h o r t - a c t i n g anes the t i c t o 
p a t i e n t s t y p i c a l l y b e t w e e n t h e 
ages of t h r e e a n d s ix . " T h i s ser-
v i c e has been v e r y successful t o 
date ," says G i l c h r e s t . " O u r p lans 
are t o have a p e d i a t r i c anes-
t h e s i o l o g i s t . D r . Joel M u m f o r d , 
present i n t h e Laser G e n t e r o n a 
regular basis so t h a t w e w i i i have 
t h e a p p r o p r i a t e pre- a n d post-seda-
t i o n care ava i lab le . " 
• FOR YOUR INFORMA TION 
Dr. Gilchrest is 
director of the 
Laser Center, is 
chief of the 
Department of 
Dermatology, 
and is chairman 
and professor of 
the Department of Dermatology 
at Boston Univers i ty School of 
Medicine. 
If y o u w o u l d l ike more infor-
m a t i o n on the laser, or on der-
matology services at U H , please 
call I -800-842-3648 during husi-
ness hours. 
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Don't 
Be a 
Yo-Yo 
Study finds that 
weight-cy ding 
by dieters may 
be hazardous 
BY G I N A D I G R A V I O 
eople w h o con-
s t a n t l y lose 
w e i g h t , o n l y t o 
rega in i t , m a y 
suffer f r o m m o r e 
t h a n j u s t f r u s t r a -
t i o n — t h e y m a y he at i n -
creased r i s k of d y i n g f r o m 
h e a r t disease. Researchers at T h e 
U n i v e r s i t y H o s p i t a l have f o u n d 
t h a t t h e r i s k of d y i n g f r o m hear t 
disease is a b o u t 70-percent h i g h e r 
i n people w i t h f l u c t u a t i n g w e i g h t 
t h a n i n t h o s e w h o s e w e i g h t stays 
reasonably steady. 
T h e s t u d y , p u b l i s h e d i n t h e 
New England Journal of 
Medicine, f o u n d t h a t m e n w h o 
l o s t a n d g a i n e d a h o u t 20 t o 30 
p o u n d s over a t w o - y e a r p e r i o d 
faced as m u c h as t w o t i m e s t h e 
r i s k of d y i n g f r o m hear t disease as 
those w h o m a i n t a i n e d a steady 
w e i g h t . W o m e n faced a h o u t one 
a n d a h a l f t i m e s t h e r i s k i f t h e y 
l o s t a n d t h e n rega ined 15 t o 20 
p o u n d s . T h e s t u d y w a s based o n 
32 years of f o l l o w - u p data o n 
3,000 m e n a n d w o m e n r a n g i n g i n 
i n i t i a l age f r o m 30 t o 62 w h o par-
t i c i p a t e d i n t h e F r a m i n g h a m 
H e a r t S t u d y . 
" I t is f a i r l y w e l l k n o w n t h a t 
h e i n g o v e r w e i g h t raises t h e 
chance of hear t disease," says Ber-
n a r d E. Kreger, M . D . , one of t h e 
a u t h o r s of t h e s t u d y a n d a m e m -
ber of t h e U H Sec t ion of G e n e r a l 
I n t e r n a l M e d i c i n e . " W h a t w e are 
n o w s t a r t i n g t o see is t h a t people 
w h o go o n d ie ts m a y p u t t h e m s e l -
ves at r i s k i f t h e y c a n n o t keep t h e 
w e i g h t of f , " he says. 
T h e r e m a y he several reasons 
for t h i s increased r i s k , a c c o r d i n g 
t o Kreger. Factors t h a t i n f l u e n c e 
c o r o n a r y r i s k , s u c h as h i o o d 
c h o l e s t e r o l levels , b l o o d pressure 
a n d blood-sugar , change w i t h 
w e i g h t f l u c t u a t i o n and m a y end 
u p w o r s e t h a n t h e y w e r e i n t i a l i y . 
Ghanges also o c c u r i n t h e a m o u n t 
a n d d i s t r i b u t i o n of b o d y f a t w h e n 
people lose a n d re g a in w e i g h t . 
For e x a m p l e , a person loses b o t h 
fa t a n d l e a n - m u s c l e t i ssue w h e n 
w e i g h t is los t . B u t w h e n w e i g h t 
is regained, i t is a l m o s t a i l fa t . 
" W e b e l i e v e i t m a y also have 
s o m e t h i n g t o do w i t h t h e k i n d s of 
f o o d people eat as t h e y rega in 
w e i g h t . O f t e n t h e y are h i g h i n 
fa t , " says Kreger. " I t m a y also 
m e a n t h a t s o m e t h i n g happens t o 
a person's m e t a b o l i s m d u r i n g 
w e i g h t s w i n g s t h a t changes b l o o d 
l i p i d s levels , b l o o d pressure a n d 
b l o o d s u g a r — a i l of w h i c h can i n -
f l u e n c e c o r o n a r y r i s k . " 
N o t o n l y do repeated w e i g h t 
f l u c t u a t i o n s increase t h e r i s k f o r 
h e a r t disease, p r i o r s tudies have 
s h o w n t h a t w h e n a n i m a l s lose a n d 
t h e n re g a in w e i g h t several t i m e s , 
t h e y t e n d t o re g a in w e i g h t m o r e 
r a p i d l y a n d lose i t m o r e s l o w l y 
w i t h each cyc le . 
A c c o r d i n g t o R o b e r t H . L e r m a n , 
M . D . , P h . D . , d i r e c t o r of t h e U H 
G i i n i c a i N u t r i t i o n U n i t , a l t h o u g h 
experts a ren ' t sure w h y w e i g h t cy-
c l i n g is so p r e v e i a n t , there m a y be 
c e r t a i n u n c o n t r o l l a b l e p h y s i o l o g i -
ca l factors at w o r k . " I t is k n o w n 
t h a t fa t c e i l s — w h i c h s h r i n k i n 
size, n o t n u m b e r , u p o n w e i g h t 
loss—seem t o have a m i n i m u m 
acceptable size. W h e n t o o m u c h 
w e i g h t is los t , t h e cei ls appear t o 
send o u t p o w e r f u l , a l t h o u g h n o t 
y e t u n d e r s t o o d , s ignals t h a t i n -
crease a p p e t i t e a n d cause dieters 
t o a b a n d o n t h e i r d ie ts , " he 
says. 
T h e b o t t o m l i n e , notes 
L e r m a n , is t h a t w e i g h t 
m a i n t e n a n c e is as i m p o r -
t a n t as w e i g h t loss a n d 
dieters s h o u l d a ppr oac h 
w e i g h t c o n t r o l as a l i f e t i m e 
e f f o r t . 
A d d s Kreger: "People 
w h o d i e t s h o u l d t a k e i t 
s e r i o u s l y a n d m o d i f y t h e i r 
e a t i n g a n d exercise h a b i t s t o en-
sure w e i g h t m a i n t e n a n c e . U n l e s s 
a p e r s o n keeps t h e w e i g h t o f f once 
i t is los t , he or she w i l l be at i n -
creased r i s k for hear t disease." 
FOR YOUR INFORMA TION 
Dr. Kreger is a 
member of the 
Evans Section 
of General 
Internal 
Medic ine at 
U H , and is an 
associate 
c l in ica l professor of medicine at 
Boston Univers i ty School of 
Medicine. 
If y o u w o u l d l ike more infor-
m a t i o n on the weigbt-cycl ing 
study, please call 1-800-842-
3648 during business hours. 
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My sister was diagnosed with 
depression. Try as I may, though, I 
just don't understand why she can 7 
snap out of it. What is depression! 
You're frustrat ion is under-
standable. Depression is a very dif-
f i cu l t disease to understand. Tbe Na-
t ional Institutes of Healtb estimates 
tbat eaeb year between 4 and 8 m i l -
l i o n Americans seek belp for depres-
sion, and 10 to 15 m i l l i o n more w i l l 
be affected but won ' t seek belp. A l l 
totalled, one in four Americans w i l l 
suffer depression i n tbeir l i fe t ime. 
Because depression is a well-estab-
lisbed illness, i t is diagnosed fair ly 
easily by mental-healtb profes-
sionals. Tbe good news is tbat about 
80 to 90 percent of cases arc treatable 
tbrougb psycbotbcrapy and/or an-
tidepressant medications and, if indi -
cated, clcctrotbcrapy. In general, the 
prognosis is relative to the severity of 
the symptoms and how early they 
were recognized and addressed. 
One way to understand depression 
is to look at the human hereavement 
process. Typically at the t ime of a 
loss—the death of a loved one or 
f inancial hardship, for example— 
people proceed tbrougb a seemingly 
innate pattern where tbat loss is eon-
fronted and accepted. First there are 
feelings of shock and denial, fo l lowed 
by acute sadness and then a period of 
m o u r n i n g heforc u l t i m a t e l y accept-
ing the reality of tbe loss. But w i t h 
cl inical depression this recovery 
process does not happen. The intro-
spective experience is a feeling of 
hopelessness or bclplessncss. 
Researchers are now focusing on 
understanding tbe bioebemieal 
mechanisms i n tbe brain tbat often 
cause depression; and many experts 
believe there may he a genetic l i n k 
for depression. W i t h a better under-
standing of both, the diagnosis and 
treatment of depression w i l l he far 
more effective. 
My 77-year-old grandmother wants 
to begin exercising, but she's afraid 
she'll hurt herself. Ts she too old to 
begin exercising! 
N o one is "too o ld" to exercise, as 
long as they know their l i m i t s . A l -
though your grandmother shouldn't 
expect exercise to he her fountain of 
youth , recent studies have shown 
tbat elders can signif icantly improve 
tbeir strength, f l e x i b i l i t y and car-
diopulmonary capacity by exercising 
regularly. A n d although experts 
don't k n o w if exercise can ward off 
illness, i t appears tbat people who arc 
i n good physical condi t ion can 
rebound more quickly f rom illness. 
The important th ing for your 
grandmother to remember is to tailor 
her exercise program to her needs 
and her capacity. Cardiopulmonary 
endurance is the most important part 
of an exercise program. The good 
news is that whi le i t used to he 
thought that a lot of exercise is 
needed to retain cardiopulmonary 
capacity, new studies show that a 
very modest amount of exercise is 
needed to mainta in and perhaps i m -
prove a person's cardiopulmonary 
level. However, heforc starting any 
exercise program, elders should eoii-
sult their physician. 
My uncle recently suffered a brain 
aneurysm and miraculously sur-
vived. Aren't brain aneurysms al-
ways fatal! 
You're right, they almost always 
arc fatal. Of those who suffer a rup-
tured brain aneurysm, only 50 per-
cent survive long enough to make i t 
to the hospital . Of those who reach 
the hospital, only half survive. 
If you or any family members or 
friends are suffering from health 
problems similar to those presented 
in these questions, and you would 
like to see an appropriate physician, 
please call 1-800-842-3648 during 
business hours. 
The information in "Health 
Notes" was derived from the Univer-
sity Hospital's "Matters of Health" 
column, a health and wellness 
column that is written in coopera-
tion with the physicians and staff of 
Boston University Medical Center. 
A brain aneurysm is a weakened 
port ion of an artery—usually located 
at the junct ion of t w o arteries at tbe 
base of tbe brain—tbat causes tbat 
port ion of tbe artery to swell l ike a 
balloon. Most aneurysms are present 
at h i r tb , and 25 percent of tbosc w i t b 
brain aneurysms bave more tban one. 
Aneurysms are sometimes called 
" t ime bombs" because tbey arc a 
silent but deadly tbreat; but some 
people l ive w i t b aneurysms all tbeir 
lives w i t b o u t problems. 
In general, tbe out look for brain 
aneurysm surgery bas greatly i m -
proved i n tbe last 10 years, w i t b bet-
ter diagnostic teebnology, more 
precise surgical tools, new surgical 
teebniques and effective medications. 
During a recent outpatient visit, my 
doctor asked if I had thought about 
a living will or durable power of at-
torney. Why would he mention that 
then! 
Tbe Uni ted States Congress 
passed tbe federal Patient Self-Deter-
m i n a t i o n Act , wbicb soon w i l l make 
i t a legal requirement tbat certain 
types of ins t i tut ions i n f o r m tbeir 
patients about tbe options available 
for documenting bow tbey want to be 
eared for sbould tbey hecome i n -
capacitated. 
Tbe advent of sueb advance direc-
tives—specific instructions for bow a 
person w o u l d l ike bis or ber care 
directed sbould be or sbc he unahle 
to make decisions—grew out of 
people's desire to control their o w n 
medical destiny. 
The hest k n o w n advance directive 
is the l i v i n g w i l l , w b i c b is a w r i t t e n 
document tbat gives instructions for 
care under certain scenarios. A varia-
t i o n of tbe l i v i n g w i l l is tbe medical 
care directive, wbicb gives more 
detailed instructions for a greater 
number of scenarios. T w o otber alter-
natives are tbe bealtb care proxy and 
tbe durable power of attorney, w b i c b 
appoint a trusted indiv idua l to make 
medical decisions on bebalf of a 
patient. 
Most inst i tut ions arc combing tbe 
instructions approaeb w i t b tbe proxy 
approacb, offering tbe opt ion of a 
proxy as w e l l as specific instructions, 
or vice versa. 
N O V E M B E R 1991, P R O G R E S S 15 
NAMES 
Freed 
• T w o of The Univers i ty Hospital 's 
most esteemed cl inical leaders have 
announced their retirements as 
chiefs. After 26 years, Murray M . 
Freed, M.D., w i l l retire as chief of the 
Department of Rehabil i tat ion 
Medicine and director of tbe N e w 
Fngland Regional Spinal Cord In jury 
Center (NFRSCIC). A n d after 18 
years, Robert E. Leach, M.D. , w i l l 
step d o w n as chief of tbe Department 
of Orthopedic Surgery and director of 
its Sports Medicine Cl in ic . D u r i n g 
tbeir distinguished careers, both 
physicians bave been giants i n tbeir 
respective fields. Freed, an interna-
t ional figure in rehabi l i tat ion 
medicine, b u i l t the NFRSCIC in to a 
model fac i l i ty of its k i n d for the care 
of spinal cord-injured patients. 
Leach, who currently is chairman of 
the Sports Medicine Counc i l for the 
U n i t e d States O l y m p i c Commit tee 
and is editor of the American Journal 
of Sports Medicine, was physician to 
the 1 9 8 4 and l9cS<S U.S. O l y m p i c 
teams and to t he Boston Bruins. 
• For the first 
t ime in its history, 
the World Health 
Organization 
(WHO), based in 
Ceneva, Switzer-
land, w i l l have a 
program that w i l l 
focus on issues af-
fecting the grow-
ing elderly populations around the 
world , part icularly i n western 
European and Asian nations. Chosen 
to head WHO's Program on Heal th of 
the Elderly was R. Knight Steel, 
M.D., who since 1977 bas been chief 
of tbe Evans Section of Ceriatries and 
medical director of tbe Hospital 's 
Home Medical Service. 
Steel 
Arkin 
• Charles Arkin, 
M . D . , bas been ap-
pointed as chief of 
tbe Department of 
Laboratory 
Medicine. Dr. 
A r k i n comes to 
U H f r o m N e w 
Fngland Deaco-
ness Hospital , 
where be bad been 
ehiei of the Cl in ica l Pathology 
Laboratories for 12 years. He 
received both his undergraduate and 
his medical degrees f r o m 
Northwestern Univers i ty i n Chicago. 
• After four years 
as acting chief of 
tbe Department of 
Nuclear Medicine, 
Rachel Powsner, 
M . D . , M . P . H . , was 
appointed chief of 
Nuclear Medicine. 
Powsner received 
ber undergraduate 
degree f r o m Massachusetts Inst i tute 
of Teebnology, ber medical degree 
f r o m Case Western Reserve Univer-
sity and ber master's degree in public 
health from the Harvard School of 
Ptdrlie Health. 
• At the Annual Meet ing of the 
Hospital's Medical-Dental Staff in 
June, tbe presidential gavel was 
passed f rom Richard K. Babayan, 
M.D., to Hartej S. Sandhu, M.D. As 
staff president i n 1990-91, Babayan, a 
urologist, played a major role i n en-
Powsner 
Sandhu Babayan 
baneing communica t ion between tbe 
staff and tbe Hospita l Board of Trus-
tees and administrat ion. This year, 
Sandhu, a psychiatrist and medical 
director of tbe Hospital 's qual i ty as-
surance programs, intends to focus on 
qual i ty assurance efforts and bui ld ing 
physician support of tbe Hospital 's 
five-year, $25 m i l l i o n Capital Cam-
paign, w h i c h began last m o n t h . 
• Tbe Boston Univers i ty Medical 
Center c o m m u n i t y suffered tragic los-
ses w i t b tbe passing of t w o prominent 
figures. William McNary Jr., Ph.D., 
tbe first dean for Student Affairs at 
Boston Univers i ty School of 
Medicine, died of cancer on May 19; 
be was 64. A beloved figure among 
McNarv 
medical students and faculty mem-
bers alike, M c N a r y graduated magna 
emu laude f r o i u Tuf t s Univers i ty and 
received bis Pb.D. f r o m Boston 
Univers i ty . "Beyond bis contribu-
tions as an anatomist, Dr. Mc N ar y 
left an indelible mark on the lives of 
our medical students for more than 
three decades. 1 le is irreplaeeahle and 
w i l l he sorely missed," said A r a m V. 
Cbohanian, M . D . , dean of BUSM. 
Henry M. Goldman, D . M . D . , found-
ing dean of the world's f irst graduate 
dental school—the Boston Univers i ty 
School of Graduate Dent is try—died 
at age 79 on July 23 after an extended 
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illness. M l . t .oldin. in. an imernatinn-
al t'iginv in pei iodnnmlngy and oral 
paiholng\ eoneeiwd and developed 
the dental sehool and SL'ixed a- dean 
I rom 1963 to DC?. The .school was 
nametl in his honor in 197s hv the 
Boston Uni\eisit\ Board ol Titistees. 
"Mr. Goldman was a great physician, 
a gn.ai educator and a gieai ad-
ministrator, as well as a geiierotis ad-
visor, wise eotinselor and \d 
l i iend. s.iid lohn R. Silher. Ph..P.. 
president of Boston Universi ty . 
— 
a t 
• L e o n a r d S. 
C.ottleib, M . I ) . . 
d u e l oi ;he 1 "tepart-
nieiit I)l Pathology, 
has been elected to 
tbe Board of Gover-
nors of tbe 
Hehrcw Univer-
sity of Jertrsalem. CoLlh'.ih 
He already is presi-
dent of the 
American Friends of the Hehrcw 
Univers i ty , New Fngland region, and 
president of the American Physicians 
Fellowship tor Medicine in Israel. 
IN THE NEWS 
Since the last issue of Progress, the fo l -
l o w i n g Boston Universitx Medical 
Center health protes.sionals have ap-
peared in the media as experts for 
news stories: 
. e l f 
Elaine Alpert, M.D., General Internal 
Medicine, wa^ interviewcd hy WBZ-
r\ Channel 4 ahout sexism i n 
medicine.. . . 
^ > Sanford Auerbach, 
, M.D., Neurology, 
was interviewed 
hy WCVB-TV 
Channel 5 about 
sleepwalk-
ing . . .David 
Felson, M.D., 
A r t h r i t i s , was i n -
terviewed hy the 
li()\i()n (dohf ahout new strategies 
and developments i n arthri t is . . . . 
Murray Freed, M.D., chief, Rebahilita-
t ion Medicine, w.is interviewed by 
People magazine, Boston Herald, and 
W B Z - T V Channel 4 about M o r l a n O'-
Bryan, a U H spinal-cord patient w h o 
took a hullet to save t w o local neigb-
borbood children. . . . Irwin Goldstein, 
M.D., Urology, Alan Greenfield, 
M.D., chief, Vascular Radiology, and 
Max Rosen, M.D., Radiology, were i n -
terviewed by USA Today, New York 
'Times, Boston 
Cdobe, WFFI-
radio, WHOl-radio 
"To Your Healtb"-
radio, W C A V - T V 
in i 'hiladelpbia, 
WKBD-T\ i n 
Detroi t , and the 
"Good Day! Show 
on a B U M C study 
that found smok-
ing to he a risk faet(.)r for i m -
potence....George Griffing, M.D., Fn-
doerinology, was interviewed hy 
W L V I - T V Channel 56 ahout thvroid 
Pochi 
disorders....Michael Holiek, M.D., 
Fndoerinology, w-as interviewed hy 
WBZ-TV Channel 4 and WCATTTV 
Channel 5 about tbe effects of 
v i t a m i n - D intoxication.. . .Joshua Kauf-
man, M.D. , Medicine, was inter-
viewed by tbe Associated Ibcss and 
Middlesex News about Mor lan O'-
Bryan....Bernard Kreger, M.D., 
General Internal Medicine, was inter-
viewed by "NBC N i g h t l y News," Bos-
ton Globe, 
W l - I D H - T V Chan-
nel 7, WBZ- TV 
Cbannel 4 and 
W C V B - T V Chan-
nel 5 about his re-
search on the ad-
verse effects of 
weight cy-
cling....John 
Murphy, Ph.D., 
chief, Biomoleeular Medicine, was i n -
terviewed by tbe Boston Globe about 
tbe potential benefits of his fusion 
tox in therapy research in 
AIDS....Peter Pochi, M.D., and Jag 
Bhawan, M.D. , Dermatology, were in -
terviewed by USA Today, United 
Press International , Boston Globe, 
Boston Herald and "To Your Health" 
radio ahout their research on how to 
reverse the effects of photodamaged 
skin. . .Philip Fodrid, M.D., Nicholas 
Ruocco, M.D., and Rodney Falk, 
M.D., Cardiology, were interviewed 
hy W L V I - T V Channel 56, W H D H - T V 
Channel 7 and WBZ-TV Channel 4, 
respectively, about President Bush's 
medical condit ion. 
Podrid 
We Want To Thank You,,. So Let Us Know,,, 
If y o u have included The Univers i ty Hospital i n your w i l l or 
trust, you are eligible for membership i n tbe Hospital 's Legacy 
Society. Tbe Legacy Society, consisting of more tban 100 mem-
bers, recognizes tbe valuable contributions of friends and staff 
w h o include Tbe Univers i ty Hospital i n tbeir estate plans. A l l 
members receive an i n v i t a t i o n to tbe Society's annual lunch-
eon, a copy of Progress magazine, and a membership token. 
Most important ly , you w i l l become a member of an organiza-
t i o n tbat is commit ted to furthering tbe goals of tbe Tbe 
U n i v e r s i t y Hospital . 
Please m a i l this coupon to Tbe Univers i ty Hospital Develop-
ment Office, 85 Fast N e w t o n Street, Boston, M A 02118. 
( ) Yes, I bave included Tbe Universi ty i lospital 
i n m y estate plan and wish to become a niemher 
of Tbe Legacy Society. 
( ) Please send me more informat ion about i n -
eluding Tbe Univers i ty Hospital i n m y w i l l or 
trust. 
Name 
Address 
C i t y State Zip_ 
Telephone 
Relationship to U H _ 
T h e U n i v e r s i t y H o s p i t a l 
at B o s t o n U n i v e r s i t y 
M e d i c a l C e n t e r 
88 East N e w t o n Street 
B o s t o n M A 02118-2383 
A d d r e s s C o r r e c t i o n Reques ted 
N o n p r o f i t O r g a n i z a t i o n 
U.S . P O S T A G E 
P A I D 
B o s t o n , M A 
P E R M I T N O . 3469 
t's the oldest word in advertising, 
and it's being used often to 
describe tbe work being done in 
The University HospitaTs Center 
for Minimal Access Surgery. 
tbe Center was founded one 
fago, tbe intent was to provide 
a dpiamic environment in wbicb 
surgeons could investigate 
"new approaches to traditional 
surgeries tbat were less traumatic 
to patients and less costly to pay-
ers. Recently, tbe Center added to 
its growing roster of teebniques tbe 
ability to remove enlarged prostate 
glands (see page 6) and repair 
hernias (see page 8). 
